Procaps Group, S.A Long Term Debt 2020-2023 | PROCF

Procaps Group, S.A long term debt from 2020 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Procaps Group, S.A Annual Long Term Debt
(Millions of US $)
2022 $28
2021 $179
2020 $352
2020 $
2019 $
2019 $
2018 $
Procaps Group, S.A Quarterly Long Term Debt
(Millions of US $)
2023-09-30 $221
2023-06-30 $170
2023-03-31 $150
2022-12-31 $28
2022-09-30 $171
2022-06-30 $182
2022-03-31 $169
2021-12-31 $179
2021-09-30 $113
2021-06-30
2021-03-31
2020-12-31 $352
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49